INBRX-106 An Open-Label, multicenter, First in Human, Dose Escalation, Phase 1/2 Study of INBRX-106 in Subjects with locally advanced or metastatic solid tumors
- Phase I
- Trial Category: Other Solid Tumor
Contact(s)
Mary Beth Wilwerding, RN Admin@NEcancertrials.com
Location(s)
Available at Nebraska Cancer Specialists, Omaha, NE locations
Interested in More Information?
Please fill out the form below. Someone will get back to you as soon as possible.
"*" indicates required fields